Long non-coding RNAs as potential biomarkers and therapeutic targets for gliomas

Medical Hypotheses

Volumn 81, Issue 2, 2013, Pages 319-321

  Sun, Yuanzhao ^a,b   Wang, Zhong ^a   Zhou, Dai ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b Second People's Hospital of Huai'an   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LONG UNTRANSLATED RNA; MICRORNA;

ARTICLE; BRAIN BIOPSY; BRAIN DEVELOPMENT; CANCER GRADING; CANCER PROGNOSIS; CANCER SCREENING; CANCER SURVIVAL; CARCINOGENESIS; CHEMORADIOTHERAPY; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GLIOMA; HISTOPATHOLOGY; HUMAN; HYPOTHESIS; PATHOGENESIS; PROTEIN EXPRESSION;

BRAIN NEOPLASMS; GLIOMA; HUMANS; MODELS, THEORETICAL; PROGNOSIS; RNA, LONG NONCODING; TUMOR MARKERS, BIOLOGICAL;

EID: 84880038197     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2013.04.010     Document Type: Article

References (44)

1. Ohgaki H., Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol 2005, 109(1):93-108.
2. Johnson D.R., Brown P.D., Galanis E., Hammack J.E. Pilocytic astrocytoma survival in adults: analysis of the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute. J Neurooncol 2012, 108(1):187-193.
3. Sadetzki S., Zach L., Chetrit A., Nass D., Hoffmann C., Ram Z., et al. Epidemiology of gliomas in Israel: a nationwide study. Neuroepidemiology 2008, 31(4):264-269.
4. Hadziahmetovic M., Shirai K., Chakravarti A. Recent advancements in multimodality treatment of gliomas. Future Oncol 2011, 7(10):1169-1183.
5. Youland RS, Khwaja SS, Schomas DA, Keating GF, Wetjen NM, Laack NN. Prognostic factors and survival patterns in pediatric low-grade gliomas over 4 decades. J Pediat Hematol Oncol 2012 [Epub ahead of print].
6. Anton K., Baehring J.M., Mayer T. Glioblastoma multiforme: overview of current treatment and future perspectives. Hematol Oncol Clin N 2012, 26(4):825-853.
7. Koga T., Saito N. Efficacy and limitations of stereotactic radiosurgery in the treatment of glioblastoma. Neurol Med Chir (Tokyo) 2012, 52(8):548-552.
8. Zhu J., Zuo J., Xu Q., Wang X., Wang Z., Zhou D. Isocitrate dehydrogenase mutations may be a protective mechanism in glioma patients. Med Hypotheses 2011, 76(4):602-603.
9. Jiang Y.G., Peng Y., Koussougbo K.S. Necroptosis: a novel therapeutic target for glioblastoma. Med Hypotheses 2011, 76(3):350-352.
10. Selek L., Mauconduit F., Nissou M.F., Nugue G., Lahrech H., Berger F., et al. Biodiversity as a barrier to glioma cell invasion. Med Hypotheses 2012, 78(4):459-461.
11. Kelly P.J. Gliomas: survival, origin and early detection. Surg Neurol Int 2010, 1:96.
12. Kesari S. Understanding glioblastoma tumor biology: the potential to improve current diagnosis and treatments. Semin Oncol 2011, 38(Suppl. 4):S2-10.
13. Assem M., Sibenaller Z., Agarwal S., Al-Keilani M.S., Alqudah M.A., Ryken T.C. Enhancing diagnosis, prognosis, and therapeutic outcome prediction of gliomas using genomics. Omics 2012, 16(3):113-122.
14. Farias-Eisner G., Bank A.M., Hwang B.Y., Appelboom G., Piazza M.A., Bruce S.S., et al. Glioblastoma biomarkers from bench to bedside: advances and challenges. Brit J Neurosurg 2012, 26(2):189-194.
15. O'Carroll D., Schaefer A. General principals of miRNA biogenesis and regulation in the brain. Neuropsychopharmacology 2013, 38(1):39-54.
16. Sheinerman KS, Umansky SR. Early detection of neurodegenerative diseases: Circulating brain-enriched microRNA. Cell Cycle 2012;12(1) [Epub ahead of print].
17. Srinivasan S., Patric I.R., Somasundaram K. A ten-microRNA expression signature predicts survival in glioblastoma. PLoS ONE 2011, 6(3):e17438.
18. Roth P., Wischhusen J., Happold C., Chandran P.A., Hofer S., Eisele G., et al. A specific miRNA signature in the peripheral blood of glioblastoma patients. J Neurochem 2011, 118(3):449-457.
19. Ilhan-Mutlu A., Wagner L., Wohrer A., Furtner J., Widhalm G., Marosi C., et al. Plasma MicroRNA-21 concentration may be a useful biomarker in glioblastoma patients. Cancer Invest 2012, 30(8):615-621.
20. Li Y., Li W., Yang Y., Lu Y., He C., Hu G., et al. MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme. Brain Res 2009, 1286:13-18.
21. Ren Y., Zhou X., Mei M., Yuan X.B., Han L., Wang G.X., et al. MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol. BMC Cancer 2010, 10:27.
22. Nikaki A., Piperi C., Papavassiliou A.G. Role of microRNAs in gliomagenesis: targeting miRNAs in glioblastoma multiforme therapy. Expert Opin Inv Drug 2012, 21(10):1475-1488.
23. Olar A., Aldape K.D. Biomarkers classification and therapeutic decision-making for malignant gliomas. Curr Treat Options Oncol 2012, 13(4):417-436.
24. Zhang L., Li H., Benedek D., Li X., Ursano R. A strategy for the development of biomarker tests for PTSD. Med Hypotheses 2009, 73(3):404-409.
25. Qureshi I.A., Mehler M.F. Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease. Nat Rev Neurosci 2012, 13(8):528-541.
26. Han L., Zhang K., Shi Z., Zhang J., Zhu J., Zhu S., et al. LncRNA pro fi le of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis. Int J Oncol 2012, 40(6):2004-2012.
27. Sui W, Yan Q, Li H, Liu J, Chen J, Li L, et al. Genome-wide analysis of long noncoding RNA expression in peripheral blood mononuclear cells of uremia patients. J Nephrol 2012. doi:10.5301/jn.5000201 [Epub ahead of print].
28. Qi P, Du X. The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Mod Pathol 2012. doi:10.1038/modpathol.2012.160 [Epub ahead of print].
29. Kapranov P., Cheng J., Dike S., Nix D.A., Duttagupta R., Willingham A.T., et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 2007, 316(5830):1484-1488.
30. Ponting C.P., Oliver P.L., Reik W. Evolution and functions of long noncoding RNAs. Cell 2009, 136(4):629-641.
31. Rinn J.L., Chang H.Y. Genome regulation by long noncoding RNAs. Annu Rev Biochem 2012, 81:145-166.
32. Harries L.W. Long non-coding RNAs and human disease. Biochem Soc Trans 2012, 40(4):902-906.
33. Moseley M.L., Zu T., Ikeda Y., Gao W., Mosemiller A.K., Daughters R.S., et al. Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8. Nat Genet 2006, 38(7):758-769.
34. Yang Z., Zhou L., Wu L.M., Lai M.C., Xie H.Y., Zhang F., et al. Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann Surg Oncol 2011, 18(5):1243-1250.
35. Chen G, Wang Z, Wang D, Qiu C, Liu M, Chen X, et al. LncRNADisease: a database for long-non-coding RNA-associated diseases. Nucleic Acids Res 2013;41(D1):D983-6.
36. Reis E.M., Verjovski-Almeida S. Perspectives of Long Non-Coding RNAs in Cancer Diagnostics. Front Genet 2012, 3:32.
37. Panzitt K., Tschernatsch M.M., Guelly C., Moustafa T., Stradner M., Strohmaier H.M., et al. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology 2007, 132(1):330-342.
38. Gibb E.A., Brown C.J., Lam W.L. The functional role of long non-coding RNA in human carcinomas. Mol Cancer 2011, 10:38.
39. Gutschner T, Hammerle M, Eissmann M, Hsu J, Kim Y, Hung G, et al. The non-coding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res 2012 [Epub ahead of print].
40. Gupta R.A., Shah N., Wang K.C., Kim J., Horlings H.M., Wong D.J., et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010, 464(7291):1071-1076.
41. Tsai M.C., Spitale R.C., Chang H.Y. Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res 2011, 71(1):3-7.
42. Zhang X., Sun S., Pu J.K., Tsang A.C., Lee D., Man V.O., et al. Long non-coding RNA expression profiles predict clinical phenotypes in glioma. Neurobiol Dis 2012, 48(1):1-8.
43. Ellis B.C., Molloy P.L., Graham L.D. CRNDE: a long Non-Coding RNA Involved in CanceR, Neurobiology, and DEvelopment. Front Genet 2012, 3:270.
44. Wang P., Ren Z., Sun P. Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation. J Cell Biochem 2012, 113(6):1868-1874.